Jeffrey Hessekiel sold $1.7M of Exelixis (EXEL)

Executed Nov 1 2024, disclosed Nov 5 2024, 4 days later.

Value, as filed

$1.7M

50,000 sh × $34.13

Executed

Nov 1 2024

the trade date, as filed

Disclosed

Nov 5 2024

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JH Jeffrey Hessekiel EVP & General Counsel profile →

Jeffrey Hessekiel (EVP & General Counsel) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.2M of EXEL (60,000 sh × $36.67, as filed), executed Nov 29 2024.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeffrey Hessekiel in EXEL

EXELSALE Exelixis, Inc. $1.2M
25,000 sh × $46.18
Exec May 15 2025
Filed May 16 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $2.2M
60,000 sh × $36.67
Exec Nov 29 2024
Filed Dec 2 2024 · 5:30 PM ET EXELSALE Exelixis, Inc. $710K
25,000 sh × $28.39
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET EXELSALE Exelixis, Inc. $660K
25,000 sh × $26.38
Exec Sep 23 2024
Filed Sep 25 2024 · 5:30 PM ET